EUVIMEDEUVIMED entdecken
Kohortenstudie

The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study

Tetsuo Kobayashi iD, Satoshi Ito, Akira Murasawa, Hajime Ishikawa, Koichi Tabeta

Modern Rheumatology · 2023

DOI: 10.1093/mr/roac093 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Tetsuo Kobayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: General Dentistry and Clinical Education Unit, Faculty of Dentistry & Medical and Dental Hospital, Niigata University, Niigata, Japan. Hauptthemen laut MEDLINE: Periodontitis, Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim is to evaluate the relevance of serum immunoglobulin G (IgG) titres against periodontopathic bacteria to predict the clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA) patients.

Methods

Data were collected from 50 RA patients who had received conventional synthetic DMARDs, corticosteroids, or non-steroidal anti-inflammatory drugs before (baseline) and after 1-year treatment with bDMARDs in a retrospective cohort study. Changes in rheumatologic conditions were compared between the two groups for low and high baseline IgG titres against Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans according to their median measurements.

Results

Twenty-five patients with low anti-P. gingivalis IgG titres showed significantly greater decreases in changes in the Clinical Disease Activity Index and swollen joint count than 25 patients with high anti-P. gingivalis IgG titres (p = .04 for both). Bivariate and multivariate analyses revealed a significantly positive association of baseline anti-P. gingivalis IgG titres with Clinical Disease Activity Index changes (p = .02 and p = .002). However, post-treatment rheumatologic conditions were comparable between 25 patients each in the low and high baseline anti-A. actinomycetemcomitans IgG titre groups.

Conclusions

Baseline serum anti-P. gingivalis IgG titres are predictive of the clinical response to 1-year treatment with bDMARDs in RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeriodontitisAntirheumatic AgentsArthritis, RheumatoidHumansPorphyromonas gingivalisRetrospective StudiesImmunoglobulin G

Stichwörter der Autor:innen

Porphyromonas gingivalisBiological disease-modifying antirheumatic drugclinical responseperiodontitisrheumatoid arthritis

Substanzen

Antirheumatic AgentsImmunoglobulin G

Autor:innen und Institutionen

  • General Dentistry and Clinical Education Unit, Faculty of Dentistry & Medical and Dental Hospital, Niigata University, Niigata, Japan.
  • Division of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan.

ORCID-Profile: Tetsuo Kobayashi

Förderung

  • KAKENHI

Zitieren

APA

Kobayashi, T., Ito, S., Murasawa, A., Ishikawa, H., & Tabeta, K. (2023). The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study. Modern Rheumatology. https://doi.org/10.1093/mr/roac093

Vancouver

Kobayashi T, Ito S, Murasawa A, Ishikawa H, Tabeta K. The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study. Modern Rheumatology. 2023. doi:10.1093/mr/roac093

BibTeX
@article{Kobayashi2023,
  author = {Kobayashi, Tetsuo and Ito, Satoshi and Murasawa, Akira and Ishikawa, Hajime and Tabeta, Koichi},
  title = {The serum immunoglobulin G titres against Porphyromonas gingivalis as a predictor of clinical response to 1-year treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: A retrospective cohort study},
  journal = {Modern Rheumatology},
  year = {2023},
  doi = {10.1093/mr/roac093}
}
Kostenlos starten →